Cancer Immunotherapeutic Potential of NKTT320, a Novel, Invariant, Natural Killer T Cell-Activating, Humanized Monoclonal Antibody is a research paper published in International Journal of Molecular Sciences (2020). On theSindex it has a DataRank of 0.454. It has been cited 8 times, with 4 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.330
From this paper's citation signal
Citation Network Contribution
0.125
From 4 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 4 citers.
NCI NIH HHS
Grant: K22 CA188149
National Institutes of Health
Grant: 5R01HL089745-02
Role of SAP,SLAM and Fyn in NKT Cell Ontogeny and Activation
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals